Bifurcation Lesions Market
Bifurcation Lesions Market Size, Share & Growth Analysis, By Type (One-stent Bifurcation Lesions, Two-stent Bifurcation Lesions), By Application (Coronary Vascular, Peripheral Vascular), & By Region - Global Market Insights 2023-2033
Analysis of Bifurcation Lesions Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Bifurcation Lesions Market Outlook (2023-2033)
The global bifurcation lesions market was valued at US$ 2.25 billion in 2022. Global sales of bifurcation lesion devices are expected to increase at a CAGR of 6% and reach a market valuation of US$ 4.26 billion by the end of 2033.
Rising demand for the treatment of coronary bifurcation lesions is due to the availability of treatments specifically designed to treat lesions near the coronary bifurcation, their greater awareness about the treatment procedures, and an increase in percutaneous coronary intervention operations.
Based on application, bifurcation lesions are categorized into coronary vascular and peripheral vascular. Demand for coronary vascular procedures is expected to increase at a similar CAGR of 6% during the next 10 years and this can be attributed to the continuing clinical trials and investments by market participants for the development of bifurcation lesion gadgets. This will probably lead to the launch of new products for coronary bifurcation lesions and expand the uses of current ones for bifurcation lesions.
Demand for peripheral vascular procedures is predicted to rise at a high CAGR of 6.5% during the forecast period. This rise may be due to the rising public knowledge of peripheral arterial diseases (PADs) and their increasing prevalence.
- The National Institutes of Health estimates that 20 percent of Americans over 50 experience PAD.
It is challenging to deploy stents in smaller peripheral arteries, so they cannot be utilised to treat PADs, so angioplasty is the preferred method of treatment. For the treatment of bifurcation lesions, stent implantation is typically chosen over balloon angioplasty.
A "bifurcation lesion" is the term used to describe the constriction of the coronary artery next to the beginning of a substantial side branch (SB). High shear stress and turbulent blood flow make it more likely to generate atherosclerotic plaque.
Techniques used in its treatment include analysis, duration of the treatment, exposure to X-rays, and long-term follow-up. To measure the bifurcation angles, multi-slice computed tomography and three-dimensional (3D) angiography are also used.
The treatment of bifurcation lesions with difficult cases is becoming possible on a global scale due to the advancements in bifurcation stenting techniques, imaging, supplementary medication, and vascular access. Demand for bifurcation lesion procedures is being fuelled by the expansion of insurance coverage for treatments for bifurcation lesions, and advancements in imaging modalities.
Furthermore, sales of bifurcation lesion devices are expected to increase healthily in the next 10 years due to ongoing clinical trials on stents and balloons for bifurcation lesion treatments and the rising occurrence of these lesions. The demand is also projected to be driven by growth in the number of experienced surgeons and a reduction in treatment-associated hazards.
Report Attributes |
Details |
|
Bifurcation Lesions Market Size (2023E) |
US$ 2.38 Billion |
|
Forecasted Market Value (2033F) |
US$ 4.26 Billion |
|
Global Market Growth Rate (2023-2033) |
6% CAGR |
|
China Market Growth Rate (2023-2033) |
10% CAGR |
|
Japan Market Growth Rate (2023-2033) |
3% CAGR |
|
Germany Market Growth Rate (2023-2033) |
4% CAGR |
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Which Opportunities Await Bifurcation Lesions Market Players?
“Rising Prevalence of CVDs among Senior Population”
Cardiovascular disorders (CVDs) are becoming more common worldwide. A high number of adults & seniors get affected by CVDs. The cases of cardiovascular disorders among the ageing population are rising globally, which further increases the chances of lesions.
- According to WHO findings, CVD is a common cause of death globally and takes more than 17 million lives each year.
- Coronary heart disease, rheumatic heart disease, cerebrovascular disease, and other illnesses are among the category of heart and blood vessel disorders known as CVDs.
- Heart attacks and strokes account for more than four out of every five CVD deaths, and one-third of these deaths happen before the age of 70.
Unhealthy eating habits, increasing sedentary lifestyles, usage of tobacco products, and drinking alcohol heavily are the main behavioural risk factors for heart disease and stroke.
Thus, the above-mentioned factors boost the demand for bifurcation lesion treatment procedures.
“High Demand for Minimally-invasive Surgeries & Advancing Healthcare Infrastructure”
The demand is being supported by the rising rate of the ageing population, who are more prone to develop medical issues and requires assistance from the government for reimbursement. Increasing demand for minimally-invasive operations, rising medical tourism, and advancing healthcare infrastructure globally are further boosting sales growth.
Apart from that, various ongoing research for developing cutting-edge bifurcation stenting treatment methods are also driving the industry’s growth.
- For, instance the effectiveness of the Szabo 2-stent method for complex bifurcation lesions with a significant risk of compromise or fatal SB blockage is being studied by researchers.
Which Factors Expected to Lower Sales Growth of Bifurcation Lesion Devices?
“High Treatment Costs & Reimbursement Issues”
The demand for stenting bifurcation lesion procedures is increasing at a healthy pace, but some factors may slow the sales growth.
High treatment costs and issues with reimbursement policies are some of the major factors likely to hamper sales growth.
How are New Entrants Gaining Ground in This Competitive Atmosphere?
“New Companies Focused on Developing Advanced Medical Solutions”
New companies in the bifurcation lesions market are focused on producing smart medical devices to build a strong position in the market as well as to earn high revenue shares.
- Echopoint Medical, a company that was established in 2018, is a pioneer in the development of advanced devices for detecting coronary artery disease and microvascular dysfunction. The business is engaged in the development of optical-fiber-based cardiac health monitoring sensors that can be integrated into medical equipment.
It has created the iKOs microcatheter, a device that can be inserted into cardiovascular devices and uses nanomaterials and sensors to detect heart problems.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Analysis
What Allows the United States to Hold a Dominant Market Position in North America?
“Rising Cases of Coronary Artery Diseases”
The United States holds a significant position in the North American market. This is due to the presence of major market players, favourable reimbursement policies, and the high spending power of the population on healthcare.
- The National Center for Health Statistics estimates that every year in the United States, coronary artery diseases (CAD) account for 1 in 4 fatalities, with 785,000 people having their first cardiac arrest and 470,000 living with myocardial infarction.
The opening of specialised clinics and greater funding for coronary stent advancements are driving sales growth in the United States.
How is Demand for Bifurcation Lesion Procedures Evolving in Germany?
“Growing Cases of Heart-related Disorders & Development of Advanced Gadgets for Bifurcations”
Germany’s market for bifurcation lesions is expected to expand at a CAGR of 4% from 2023 to 2033. Rising cases related to heart disorders and ongoing efforts of major manufacturers to develop gadgets for bifurcation lesions with the help of advanced technologies are expected to increase sales growth.
Also, the growing geriatric population with heart disorders, ongoing advancements in R&D, and the high prevalence of chronic disorders will all contribute toward market growth.
Why are Coronary Bifurcation Lesion Treatment Procedures Different in Japan & South Korea?
“Most Coronary Cases are Noted in Both Nations But Treatment Procedures Vary Due to Conceptual or Philosophical Differences”
Coronary bifurcation lesions vary between countries due to variations in lesion severity assessments and treatment methods.
In the Asian region, Japan and South Korea perform the most coronary procedures each year, and both physiologic and imaging guidance are common in these nations. However, due to conceptual or philosophical differences, these nations have different procedures for treating bifurcation.
- For instance, according to a study by National Center for Biotechnology Information,
- To optimise the bifurcation PCI, medical professionals in Japan closely follow imaging guidance at both the pre-and post-percutaneous coronary intervention (PCI) as well as after major arteries stenting, while proximal optimization technique (POT)/re-POT and the recently advised fractional flow reserve (FFR)/instantaneous wave-free ratio (iFR) assessment are frequently used by medical professionals in South Korea.
Thus, the interventions for bifurcation coronary stenting vary between both countries.
Category-wise Analysis
When are Two-stent Bifurcation Lesion Method Preferred?
“Tw0-stent Bifurcation Procedure Particularly Preferred in Cases of Large Lesions”
Based on type, the bifurcation lesions are divided into one-stent bifurcation lesions and two-stent bifurcation lesions.
Optimal treatment methods for percutaneous coronary intervention (PCI) of bifurcation lesions are still up for debate. Drug-eluting stents have gradually replaced balloon angioplasty and bare metal stents in the medical field.
If stenting is employed, one important consideration is whether the main vessel and the side branch should both be stented.
The favourable post-procedural angiographic outcomes of double stenting make it appealing. However, long-term significant adverse cardiac events, particularly stent thrombosis with neighbouring stents, have raised some concerns.
But, in cases with a particularly large bifurcation branch, such as main stem lesions or lesions involving bifurcation branches with a diameter almost as large as that of the main branch, double stenting / two-stent bifurcation lesions may be preferred.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Competitive Landscape
Key players in the global bifurcation lesions market are developing improved solutions by employing innovative technologies. They are also focusing on collaborations and purchases to improve their product line and generate more income.
- On June 10, 2019, eight interventional product categories underwent new group purchasing product agreements with Premier owing to Cordis, a Cardinal Health Company.
- A brand-new, innovative radial to periphery self-expanding stent was introduced by Terumo in September 2019. The corporation benefited from the introduction of this new product by growing its product line and increasing income.
- Abbott announced the introduction of Ultreon 1.0 Software powered by Al, a coronary imaging platform, in Europe in April 2021. The software's goal is to increase calcium-based blockage identification and artery diameter measurement while coronary stenting operations.
Key Segments of Bifurcation Lesions Industry Research
-
By Type :
- One-stent Bifurcation Lesions
- Two-stent Bifurcation Lesions
-
By Application :
- Coronary Vascular
- Peripheral Vascular
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Type modifications /Innovation 4. Key Success Factors 4.1. Strategic Developments 4.2. Key regulations 4.3. Type USPs /Technology 4.4. List of Manufacturers and Providers 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP outlook 5.1.2. Increasing R&D Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. New Type launches 5.2.2. Cost of Types 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID19 Crisis Analysis 6.1. Current COVID19 Statistics and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. Current Economic Projection as Compared to 2008 Economic analysis 6.4. COVID19 and Impact Analysis 6.4.1. Revenue By Type 6.4.2. Revenue By Application 6.4.3. Revenue By Country 6.5. 2022 Market Scenario 6.6. Quarter by Quarter Forecast 6.7. Projected Recovery Quarter 7. Global Market Volume (Units) Analysis 2018-2022 and Forecast, 2023-2033 7.1. Historical Market Volume (Units) Analysis, 2018-2022 7.2. Current and Future Market Volume (Units) Projections, 2023-2033 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis By Type 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global Market Value Analysis 2018–2022 and Forecast, 2023-2033 9.1. Historical Market Value (US$ Mn) Analysis, 2018–2022 9.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2018–2022 and Forecast 2023-2033, by Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Types & Services, 2018–2022 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2023-2033 10.3.1. One-stent Bifurcation Lesions 10.3.2. Two-stent Bifurcation Lesions 10.4. Market Attractiveness Analysis By Type 11. Global Market Analysis 2018–2022 and Forecast 2023-2033, by Application 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By Application , 2018–2022 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application , 2023-2033 11.3.1. Coronary Vascular 11.3.2. Peripheral Vascular 11.4. Market Attractiveness Analysis By Application 12. Global Market Analysis 2018–2022 and Forecast 2023-2033, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2018–2022 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2023-2033 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Market Analysis 2018–2022 and Forecast 2023-2033 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018–2022 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Type 13.3.3. By Application 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Market Analysis 2018–2022 and Forecast 2023-2033 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018–2022 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Type 14.3.3. By Application 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Europe Market Analysis 2018–2022 and Forecast 2023-2033 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018–2022 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. Rest of Europe 15.3.2. By Type 15.3.3. By Application 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Market Analysis 2018–2022 and Forecast 2023-2033 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018–2022 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Type 16.3.3. By Application 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. East Asia Market Analysis 2018–2022 and Forecast 2023-2033 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018–2022 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.1.4. Rest of East Asia 17.3.2. By Type 17.3.3. By Application 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Market Analysis 2018–2022 and Forecast 2023-2033 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018–2022 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Type 18.3.3. By Application 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Market Analysis 2018–2022 and Forecast 2023-2033 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018–2022 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. South Africa 19.3.1.3. Rest of Middle East and Africa 19.3.2. By Type 19.3.3. By Application 19.4. Market Attractiveness Analysis 19.5. Drivers and Restraints - Impact Analysis 20. Key and Emerging Countries Market Analysis 2018–2022 and Forecast 2023-2033 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. U.S. Market Analysis 20.2.1. By Type 20.2.2. By Application 20.3. Canada Market Analysis 20.3.1. By Type 20.3.2. By Application 20.4. Mexico Market Analysis 20.4.1. By Type 20.4.2. By Application 20.5. Brazil Market Analysis 20.5.1. By Type 20.5.2. By Application 20.6. U.K. Market Analysis 20.6.1. By Type 20.6.2. By Application 20.7. Germany Market Analysis 20.7.1. By Type 20.7.2. By Application 20.8. France Market Analysis 20.8.1. By Type 20.8.2. By Application 20.9. Italy Market Analysis 20.9.1. By Type 20.9.2. By Application 20.10. Spain Market Analysis 20.10.1. By Type 20.10.2. By Application 20.11. BENELUX Market Analysis 20.11.1. By Type 20.11.2. By Application 20.12. Russia Market Analysis 20.12.1. By Type 20.12.2. By Application 20.13. China Market Analysis 20.13.1. By Type 20.13.2. By Application 20.14. Japan Market Analysis 20.14.1. By Type 20.14.2. By Application 20.15. South Korea Market Analysis 20.15.1. By Type 20.15.2. By Application 20.16. India Market Analysis 20.16.1. By Type 20.16.2. By Application 20.17. ASEAN Market Analysis 20.17.1. By Type 20.17.2. By Application 20.18. Australia Market Analysis 20.18.1. By Type 20.18.2. By Application 20.19. New Zealand Market Analysis 20.19.1. By Type 20.19.2. By Application 20.20. GCC Countries Market Analysis 20.20.1. By Type 20.20.2. By Application 20.21. Turkey Market Analysis 20.21.1. By Type 20.21.2. By Application 20.22. South Africa Market Analysis 20.22.1. By Type 20.22.2. By Application 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Concentration 21.3. Market Share Analysis of Top Players 21.4. Market Presence Analysis 21.4.1. By Regional footprint of Players 21.4.2. Type foot print by Players 21.4.3. Channel Foot Print by Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep dive 22.3.1. Abbott 22.3.1.1. Overview 22.3.1.2. Type Portfolio 22.3.1.3. Profitability by Market Segments (Type/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.2. Boston Scientific Corporation 22.3.2.1. Overview 22.3.2.2. Type Portfolio 22.3.2.3. Profitability by Market Segments (Type/Channel/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.3. C. R. Bard, Inc. 22.3.3.1. Overview 22.3.3.2. Type Portfolio 22.3.3.3. Profitability by Market Segments (Type/Channel/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.4. Cardinal Health 22.3.4.1. Overview 22.3.4.2. Type Portfolio 22.3.4.3. Profitability by Market Segments (Type/Channel/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.5. Johnson& Johnson Services, Inc. 22.3.5.1. Overview 22.3.5.2. Type Portfolio 22.3.5.3. Profitability by Market Segments (Type/Channel/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.6. Medtronic 22.3.6.1. Overview 22.3.6.2. Type Portfolio 22.3.6.3. Profitability by Market Segments (Type/Channel/Region) 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.7. Spectranetics 22.3.7.1. Overview 22.3.7.2. Type Portfolio 22.3.7.3. Profitability by Market Segments (Type/Channel/Region) 22.3.7.4. Sales Footprint 22.3.7.5. Strategy Overview 22.3.8. Terumo Medical Corporation 22.3.8.1. Overview 22.3.8.2. Type Portfolio 22.3.8.3. Profitability by Market Segments (Type/Channel/Region) 22.3.8.4. Sales Footprint 22.3.8.5. Strategy Overview 23. Assumptions and Acronyms Used 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2018–2033, By Type
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Type
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Application
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2018-2022 and Forecast 2022–2032, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Type
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Application
Table 08: Latin America Market Value (US$ Mn) Analysis 2018-2022 and Forecast 2022–2032, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Type
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Application
Table 11: Europe Market Value (US$ Mn) Analysis 2018-2022 and Forecast 2022–2032, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Type
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Application
Table 14: South Asia Market Value (US$ Mn) Analysis 2018-2022 and Forecast 2022–2032, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Type
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Application
Table 17: East Asia Market Value (US$ Mn) Analysis 2018-2022 and Forecast 2022–2032, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Type
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Application
Table 20: Oceania Market Value (US$ Mn) Analysis 2018-2022 and Forecast 2022–2032, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Type
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Application
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2018-2022 and Forecast 2022–2032, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Type
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Application
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2018-2022
Figure 02: Global Market Volume Forecast (in 000' Units), 2023-2033
Figure 03: Pricing Analysis (US$) Per Type, By Region, 2022
Figure 04: Pricing Analysis (US$) Per Type, By Region, 2022
Figure 05: Global Market Value Analysis (US$ Mn), 2018-2022
Figure 06: Global Market Value Forecast (US$ Mn), 2023-2033
Figure 07: Global Market Absolute $ Opportunity, 2023-2033
Figure 08: Global Market Share Analysis (%), By Type, 2023-2033
Figure 09: Global Market Y-o-Y Analysis (%), By Type, 2023-2033
Figure 10: Global Market Attractiveness Analysis by Type, 2023-2033
Figure 11: Global Market Share Analysis (%), By Application, 2023-2033
Figure 12: Global Market Y-o-Y Analysis (%), By Application, 2023-2033
Figure 13: Global Market Attractiveness Analysis by Application, 2023-2033
Figure 14: Global Market Share Analysis (%), By Region, 2023-2033
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2023-2033
Figure 16: Global Market Attractiveness Analysis by Region, 2023-2033
Figure 17: North America Market Value Share, By Type, 2022 (E)
Figure 18: North America Market Value Share, By Application, 2022 (E)
Figure 19: North America Market Value Share, By Country, 2022 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2018-2022
Figure 21: North America Market Value Forecast (US$ Mn), 2023-2033
Figure 22: North America Market Attractiveness Analysis by Type, 2023-2033
Figure 23: North America Market Attractiveness Analysis by Application, 2023-2033
Figure 24: North America Market Attractiveness Analysis by Country, 2023-2033
Figure 25: Latin America Market Value Share, By Type, 2022 (E)
Figure 26: Latin America Market Value Share, By Application, 2022 (E)
Figure 27: Latin America Market Value Share, By Country, 2022 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2018-2022
Figure 29: Latin America Market Value Forecast (US$ Mn), 2023-2033
Figure 30: Latin America Market Attractiveness Analysis by Type, 2023-2033
Figure 31: Latin America Market Attractiveness Analysis by Application, 2023-2033
Figure 32: Latin America Market Attractiveness Analysis by Country, 2023-2033
Figure 33: Europe Market Value Share, By Type, 2022 (E)
Figure 34: Europe Market Value Share, By Application, 2022 (E)
Figure 35: Europe Market Value Share, By Country, 2022 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2018-2022
Figure 37: Europe Market Value Forecast (US$ Mn), 2023-2033
Figure 38: Europe Market Attractiveness Analysis by Type, 2023-2033
Figure 39: Europe Market Attractiveness Analysis by Application, 2023-2033
Figure 40: Europe Market Attractiveness Analysis by Country, 2023-2033
Figure 41: South Asia Market Value Share, By Type, 2022 (E)
Figure 42: South Asia Market Value Share, By Application, 2022 (E)
Figure 43: South Asia Market Value Share, By Country, 2022 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2018-2022
Figure 45: South Asia Market Value Forecast (US$ Mn), 2023-2033
Figure 46: South Asia Market Attractiveness Analysis by Type, 2023-2033
Figure 47: South Asia Market Attractiveness Analysis by Application, 2023-2033
Figure 48: South Asia Market Attractiveness Analysis by Country, 2023-2033
Figure 49: East Asia Market Value Share, By Type, 2022 (E)
Figure 50: East Asia Market Value Share, By Application, 2022 (E)
Figure 51: East Asia Market Value Share, By Country, 2022 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2018-2022
Figure 53: East Asia Market Value Forecast (US$ Mn), 2023-2033
Figure 54: East Asia Market Attractiveness Analysis by Type, 2023-2033
Figure 55: East Asia Market Attractiveness Analysis by Application, 2023-2033
Figure 56: East Asia Market Attractiveness Analysis by Country, 2023-2033
Figure 57: Oceania Market Value Share, By Type, 2022 (E)
Figure 58: Oceania Market Value Share, By Application, 2022 (E)
Figure 59: Oceania Market Value Share, By Country, 2022 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2018-2022
Figure 61: Oceania Market Value Forecast (US$ Mn), 2023-2033
Figure 62: Oceania Market Attractiveness Analysis by Type, 2023-2033
Figure 63: Oceania Market Attractiveness Analysis by Application, 2023-2033
Figure 64: Oceania Market Attractiveness Analysis by Country, 2023-2033
Figure 65: Middle East and Africa Market Value Share, By Type, 2022 (E)
Figure 66: Middle East and Africa Market Value Share, By Application, 2022 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2022 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2018-2022
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2023-2033
Figure 70: Middle East and Africa Market Attractiveness Analysis by Type, 2023-2033
Figure 71: Middle East and Africa Market Attractiveness Analysis by Application, 2023-2033
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2023-2033
Figure 73: U. S. Market Value Analysis (US$ Mn), 2023 & 2033
Figure 74: U. S. Market Value Share, By Type, 2022 (E)
Figure 75: U. S. Market Value Share, By Application, 2022 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2023 & 2033
Figure 77: Canada Market Value Share, By Type, 2022 (E)
Figure 78: Canada Market Value Share, By Application, 2022 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2023 & 2033
Figure 80: Mexico Market Value Share, By Type, 2022 (E)
Figure 81: Mexico Market Value Share, By Application, 2022 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2023 & 2033
Figure 83: Brazil Market Value Share, By Type, 2022 (E)
Figure 84: Brazil Market Value Share, By Application, 2022 (E)
Figure 85: U. K. Market Value Analysis (US$ Mn), 2023 & 2033
Figure 86: U. K. Market Value Share, By Type, 2022 (E)
Figure 87: U. K. Market Value Share, By Application, 2022 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2023 & 2033
Figure 89: Germany Market Value Share, By Type, 2022 (E)
Figure 90: Germany Market Value Share, By Application, 2022 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2023 & 2033
Figure 92: France Market Value Share, By Type, 2022 (E)
Figure 93: France Market Value Share, By Application, 2022 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2023 & 2033
Figure 95: Italy Market Value Share, By Type, 2022 (E)
Figure 96: Italy Market Value Share, By Application, 2022 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2023 & 2033
Figure 98: Spain Market Value Share, By Type, 2022 (E)
Figure 99: Spain Market Value Share, By Application, 2022 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2023 & 2033
Figure 101: Russia Market Value Share, By Type, 2022 (E)
Figure 102: Russia Market Value Share, By Application, 2022 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2023 & 2033
Figure 104: China Market Value Share, By Type, 2022 (E)
Figure 105: China Market Value Share, By Application, 2022 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2023 & 2033
Figure 107: Japan Market Value Share, By Type, 2022 (E)
Figure 108: Japan Market Value Share, By Application, 2022 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2023 & 2033
Figure 110: South Korea Market Value Share, By Type, 2022 (E)
Figure 111: South Korea Market Value Share, By Application, 2022 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2023 & 2033
Figure 113: India Market Value Share, By Type, 2022 (E)
Figure 114: India Market Value Share, By Application, 2022 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2023 & 2033
Figure 116: ASEAN Market Value Share, By Type, 2022 (E)
Figure 117: ASEAN Market Value Share, By Application, 2022 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2023 & 2033
Figure 119: Australia Market Value Share, By Type, 2022 (E)
Figure 120: Australia Market Value Share, By Application, 2022 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2023 & 2033
Figure 122: New Zealand Market Value Share, By Type, 2022 (E)
Figure 123: New Zealand Market Value Share, By Application, 2022 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2023 & 2033
Figure 125: GCC Countries Market Value Share, By Type, 2022 (E)
Figure 126: GCC Countries Market Value Share, By Application, 2022 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2023 & 2033
Figure 128: Turkey Market Value Share, By Type, 2022 (E)
Figure 129: Turkey Market Value Share, By Application, 2022 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2023 & 2033
Figure 131: South Africa Market Value Share, By Type, 2022 (E)
Figure 132: South Africa Market Value Share, By Application, 2022 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the bifurcation lesions market?
Global sales of bifurcation lesion devices are valued at US$ 2.38 billion in 2023 and are predicted to reach US$ 4.26 billion by 2033.
What is the estimated CAGR for the bifurcation lesions market?
The global bifurcation lesions market is likely to increase at a CAGR of 6% during the forecast period.
Which are the top bifurcation lesions markets?
The U.S., Germany, Japan, and South Korea are leading markets for bifurcation lesions.
Which factors are driving the demand for bifurcation lesion procedures?
Rising cases of coronary artery diseases, increasing investments in R&D, and production of advanced medical devices for lesion treatments are driving product sales growth.
Who are the top 3 companies in this space?
Cardinal Health Company, Terumo, and Abbott are leading manufacturers of bifurcation lesion devices.
Bifurcation Lesions Market